Treace Medical Concepts, Inc.

NASDAQ:TMCI

10.51 (USD) • At close February 4, 2025
Bedrijfsnaam Treace Medical Concepts, Inc.
Symbool TMCI
Munteenheid USD
Prijs 10.51
Beurswaarde 654,742,521
Dividendpercentage 0%
52-weken bereik 3.92 - 15.98
Industrie Medical Devices
Sector Healthcare
CEO Mr. John T. Treace
Website https://www.treace.com

An error occurred while fetching data.

Over Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and

Vergelijkbare Aandelen

Cerus Corporation logo

Cerus Corporation

CERS

1.86 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

56.99 USD

Procaps Group S.A. logo

Procaps Group S.A.

PROC

1.01 USD

OrthoPediatrics Corp. logo

OrthoPediatrics Corp.

KIDS

24.26 USD

National Research Corporation logo

National Research Corporation

NRC

16.28 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

8.43 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

11 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

14.41 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

50.21 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)